Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 26, 2020; 8(22): 5529-5534
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5529
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5529
Table 1 The comparison of levels of osteoprotegerin, interleukin-1β and hepatocyte growth factor between the two groups
Group | OPG, pmol/L | IL-1β, ng/L | HGF |
Observation group | 1.94 ± 0.09 | 145.65 ± 9.45 | 5.65 ± 1.65 |
Control group | 2.24 ± 0.14 | 45.65 ± 6.45 | 11.65 ± 2.56 |
t | 11.957 | 57.976 | 13.069 |
P value | 0.001 | 0.001 | 0.001 |
Table 2 Correlation between gestational diabetes mellitus and gestational hypertension and osteoprotegerin, interleukin-1β and hepatocyte growth factor
Indicators | GDM and gestational hypertension | |
r | P value | |
OPG | -0.556 | < 0.05 |
IL-1β | 0.456 | < 0.05 |
HGF | -0.659 | < 0.05 |
- Citation: Huang SJ, Wang HW, Wu HF, Wei QY, Luo S, Xu L, Guan HQ. Osteoprotegerin, interleukin and hepatocyte growth factor for prediction of diabetes and hypertension in the third trimester of pregnancy. World J Clin Cases 2020; 8(22): 5529-5534
- URL: https://www.wjgnet.com/2307-8960/full/v8/i22/5529.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i22.5529